Development of nanoparticle mucosal delivery systems for siRNA-based cancer therapies (2011–2012)

New gene-based treatments for cancers and infectious diseases show great promise in the laboratory but cannot reach their full potential due to lack of effective delivery systems. We are developing novel delivery systems for gene silencing therapy for cancers. We are also testing new immune enhancers that boost the body¿s ability to fight cancer and improve treatments. Testing will be undertaken on cervical cancer in the first instance.
Grant type:
Cancer Council Queensland
  • Senior Lecturer
    School of Pharmacy
    Faculty of Health and Behavioural Sciences
Funded by:
Cancer Council Queensland